We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+7.13%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$51.6B
AUM Growth
+$2.66B
Cap. Flow
+$885M
Cap. Flow %
1.72%
Top 10 Hldgs %
11.65%
Holding
2,448
New
225
Increased
918
Reduced
928
Closed
240

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$161M
2
TFC icon
Truist Financial
TFC
+$124M
3
BZUN
Baozun
BZUN
+$110M
4
STEP icon
StepStone Group
STEP
+$98M
5
CCI icon
Crown Castle
CCI
+$91.6M

Sector Composition

Rank Sector Weight
1 Healthcare 21.36%
2 Technology 19.99%
3 Financials 11.95%
4 Consumer Discretionary 9.72%
5 Industrials 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTT icon
2076
inTEST
INTT
$143M
$4K ﹤0.01%
+371
New +$3.17K
LSCC icon
2077
Lattice Semiconductor
LSCC
$16B
$4K ﹤0.01%
93
-313
-77% -$13.9K
REX icon
2078
REX American Resources
REX
$1.39B
$4K ﹤0.01%
258
SYBX
2079
DELISTED
Synlogic
SYBX
$4K ﹤0.01%
+75
New +$4.27K
TPB icon
2080
Turning Point Brands
TPB
$1.48B
$4K ﹤0.01%
68
-225
-77% -$11.2K
TZOO icon
2081
Travelzoo
TZOO
$76.7M
$4K ﹤0.01%
+251
New +$3.28K
MTUS icon
2082
Metallus
MTUS
$833M
$4K ﹤0.01%
+335
New +$2.5K
PTVE
2083
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$4K ﹤0.01%
+326
New +$5.06K
CBAY
2084
DELISTED
Cymabay Therapeutics
CBAY
$4K ﹤0.01%
829
+504
+155% +$2.71K
HARP
2085
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$4K ﹤0.01%
+17
New +$3.41K
RDS.A
2086
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$4K ﹤0.01%
+109
New +$4.39K
ABUS icon
2087
Arbutus Biopharma
ABUS
$847M
$3K ﹤0.01%
+996
New +$3.84K
ARLO icon
2088
Arlo Technologies
ARLO
$1.58B
$3K ﹤0.01%
414
+9
+2% +$71
DDD icon
2089
3D Systems Corp
DDD
$405M
$3K ﹤0.01%
+124
New +$4.1K
DEO icon
2090
Diageo
DEO
$49.6B
$3K ﹤0.01%
20
-10
-33% -$1.64K
DMAC icon
2091
DiaMedica Therapeutics
DMAC
$341M
$3K ﹤0.01%
285
+217
+319% +$2.03K
HBIO icon
2092
Harvard Bioscience
HBIO
$27.6M
$3K ﹤0.01%
+60
New +$2.92K
LE icon
2093
Lands' End
LE
$378M
$3K ﹤0.01%
+138
New +$4.05K
LPG icon
2094
Dorian LPG
LPG
$1.96B
$3K ﹤0.01%
+234
New +$3.1K
NHI icon
2095
National Health Investors
NHI
$3.79B
$3K ﹤0.01%
38
-11
-22% -$768
PDM
2096
Piedmont Realty Trust
PDM
$1.24B
$3K ﹤0.01%
150
-18
-11% -$304
PETS icon
2097
PetMed Express
PETS
$42.3M
$3K ﹤0.01%
+81
New +$2.82K
PHG icon
2098
Philips
PHG
$25.5B
$3K ﹤0.01%
74
-53
-42% -$2.41K
ROG icon
2099
Rogers Corp
ROG
$2.08B
$3K ﹤0.01%
14
-56
-80% -$10K
VKTX icon
2100
Viking Therapeutics
VKTX
$3.88B
$3K ﹤0.01%
468
-47
-9% -$331

Similar funds

Federated Hermes's Q1 2021 Portfolio in Review

As of Q1 2021, Federated Hermes held 2,448 positions worth $51.6B, up 5.4% from $48.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Federated Hermes's Q1 2021 filing shows 225 new, 918 increased, 928 reduced and 240 closed positions. Its largest new stake was Qualtrics International Inc. Class A Common Stock: 1,548,830 shares worth $51M. The largest sale was Alibaba, an estimated $438M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q1 2021 buy was Qualtrics International Inc. Class A Common Stock: 1,548,830 shares worth $51M.
  • Federated Hermes added most to US Bancorp in Q1 2021, an estimated $161M increase.
  • Federated Hermes's biggest Q1 2021 reduction was Alibaba, cutting an estimated $438M.
  • Federated Hermes fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, selling an estimated $213M.
  • Federated Hermes's ten largest holdings make up 12% of its $51.6B portfolio in Q1 2021.
  • Federated Hermes opened 225 new positions and closed 240 in Q1 2021.
  • Federated Hermes's portfolio value rose 5.4% quarter-over-quarter to $51.6B.

Based on Federated Hermes's 13F filing for Q1 2021, filed 13 May 2021.